ABT

NYSEStock

Abbott Laboratories

$108.89-1.35 (-1.23%)

52-Week Range

$106.05
$138.08

Key Stats

Market Cap

189.2B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.74

Volume

6.9M

Avg Volume

8.9M

Performance

1M

-4.80%

3M

-15.82%

6M

-17.66%

YTD

-12.92%

1Y

-16.74%

3Y

+9.73%

5Y

-8.43%

Price Chart

ETF Exposure

ABT is held by 366 ETFs

ETFFund NameWeight
VETSPacer Military Times Best Employers ETF0.04%
VIRSPacer BioThreat Strategy ETF0.04%
ITDBiShares LifePath Target Date 2030 ETF0.04%
AFTYPacer CSOP FTSE China A50 ETF0.04%
AOMiShares Core 40/60 Moderate Allocation ETF0.04%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.04%
IRTRiShares LifePath Retirement ETF0.04%
AOKiShares Core 30/70 Conservative Allocation ETF0.03%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.03%
RVRSArrow Reverse Cap 500 ETF0.02%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.02%
BBAGJPMorgan BetaBuilders U.S. Aggregate Bond ETF0.01%
LVHBInnovator Laddered Allocation Power Buffer ETF0.01%
VALTETFMG Sit Ultra Short ETF0.00%
SILXETFMG Prime 2x Daily Junior Silver Miners ETF0.00%
PreviousPage 8 of 8

About ABT ETF Exposure

Abbott Laboratories (ABT) is held by 366 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 189.2B, ABT is a widely held institutional stock. The stock currently trades at $108.89. Investors can gain exposure to ABT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ABT, sorted by portfolio weight.